Supplementary immunization activities to achieve measles elimination: Experience of the European region

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 1, 2011, Pages

  Khetsuriani, Nino ^a   Deshevoi, Sergei ^b   Goel, Ajay ^b   Spika, John ^b,c   Martin, Rebecca ^b   Emiroglu, Nedret ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MEASLES RUBELLA VACCINE; MEASLES VACCINE;

ADOLESCENT; ADULT; ANAPHYLAXIS; ARTHRALGIA; ARTICLE; BRAIN DISEASE; CHILD; DISEASE SURVEILLANCE; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; ENCEPHALITIS; EUROPE; EXPERIENCE; GUILLAIN BARRE SYNDROME; HEALTH CARE QUALITY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTERNATIONAL COOPERATION; MALE; MEASLES; MEASLES VACCINATION; MORBIDITY; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SUPPLEMENTARY IMMUNIZATION ACTIVITY; SYNCOPE; THROMBOCYTOPENIA; TREATMENT OUTCOME; FEMALE; HEALTH SURVEY; INCIDENCE; INFANT; TIME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; MALE; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 79960885022     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir074     Document Type: Article

References (23)

1. WHO. Strategic plan for measles and congenintal rubella infection in the WHO European Region. http://www.euro.who.int/document/e81567.pdf. http://www.euro.who.int/document/e81567.pdf Vol 2009. Copenhagen, Denmark: WHO Regional Office for Europe. 2003.
2. WHO. Measles vaccines: WHO position paper. Weekly Epidemiological Rec 2009; 84:349-60.
3. De Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G. Progress toward measles eradication in the region of the Americas. J Infect Dis 2003; 187(Suppl 1):S102-10.
4. Spika JS, Wassilak S, Pebody R, et al. Measles and rubella in the World health Organization European region: diversity creates challenges. J Infect Dis 2003; 187:S191-7.
5. Doshi S, Khetsuriani N, Zakhashvili K, Baidoshvili L, Imnadze P, Uzicanin A. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts. Int J Epidemiol 2009; 38:182-91.
6. Velicko I, Muller LL, Pebody R, et al. Nationwide measles epidemic in Ukraine: the effect of low vaccine effectiveness. Vaccine 2008; 26:6980-5.
7. Pistol A, Hennessey K, Pitigoi D, et al. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. J Infect Dis 2003; 187(Suppl 1):S217-22.
8. EUVAC.NET. Report of the 6th annual meeting. Copenhagen, 29-30 May 2008. Copenhagen, Denmark: Statens Serum Institute, 2009. http://www.euvac.net/ graphics/euvac/pdf/meeting-2008.pdf.
9. Ramsay ME, Jin L, White J, Litton P, Cohen B, Brown D. The elimination of indigenous measles transmission in England and Wales. J Infect Dis 2003; 187(Suppl. 1):S198-207.
10. Measles once again endemic in the United Kingdom. Euro Surveill 2008; 13:1.
11. CDC. Progress toward measles elimination-European Region, 2005-2008. MMWR Morb Mortal Wkly Rep 2009; 58:142-5.
12. Muscat M, Bang H, Wohlfahrt J, Glismann S, Molbak K. Measles in Europe: an epidemiological assessment. Lancet 2009; 373:383-9.
13. WHO. Monitoring immunization services using the lot quality technique. Geneva: WHO, 1996.
14. WHO. WHO/UNICEF joint reporting process. http://www.who.int/immunization- monitoring/routine/joint-reporting/en/index.html Accessed 27 February 2011.
15. Marinova L, Kojouharova N, Mihneva Z. An oingoing measles outbreak in Bulgaria, 2009. Euro Surveill 2009; 14: http://www.eurosurveillance.org/images/ dynamic/EE/V14N26/art19259.pdf.
16. Danilova M. Vaccine scare threatens health in Ukraine. Kiev, Ukraine: Associated Press, 2008.
17. Khetsuriani N, Imnadze P, Baidoshvili L, et al. Impact of unfounded vaccine safety concerns on the nationwide measles-rubella immunization campaign, Georgia, 2008. Vaccine 2010; 28:6455-62.
18. WHO. Health 21: the health for all policy framework for the WHO European Region. Vol. 6. Copenhagen, Denmark: WHO Regional Office for Europe, 1999. European Health for All Series.
19. Plotkin SA, Sa R. Mumps vaccine. In: Plotkin SA, Orenstein WA, PA O eds. Vaccines, 5th ed. Saunders Elsevier, 2008; 435-65.
20. Bernard H, Schwarz NG, Melnic A, et al. Mumps outbreak ongoing since October 2007 in the Republic of Moldova. Euro Surveill 2008: 13. http://www.eurosurveillance.org/images/dynamic/EE/V13N13/art8079.pdf. Accessed 27 February 2011.
21. Health Protection Agency. MMR catch-up announced. http://www.hpa.org.uk/ hpr/archives/2008/news3208.htm#mmr.Health Protection Report 2008; 2. Accessed 27 February 2011.
22. Bonanni PBA, Boccalini S, Peruzzi M, et al, Progress in Italy in control and elimination of measles and congenital rubella. Vaccine 2007; 25:3105-10.
23. WHO. European immunization week. http://www.euro.who.int/eiw. Accessed 27 February 2011.